Revolution Medicines is a late-stage clinical oncology company focused on developing targeted therapies for patients with RAS-addicted cancers. Our innovative R&D pipeline features RAS(ON) inhibitors tailored to suppress various oncogenic variants of RAS proteins, setting us apart in the fight against difficult-to-treat cancers.
No jobs found
Try different keywords or remove some filters.
Or create a free account and we’ll email you when new jobs match what you’re looking for.
Create a free account
Searching
Want job alerts that match your preferences?
Set up job preferences →